Inhaled Epoprostenol Use in Patients with SARS-CoV2-Related Severe Hypoxemic Respiratory Failure
DOI:
https://doi.org/10.58877/japaj.v1i3.58Keywords:
Epoprostenol, SARS-CoV2, COVID-19, respiratory failure, ventilator, high flow nasal cannula, non-invasive positive pressure ventilationReferences
Searcy RJ, Morales JR, Ferreira JA, Johnson DW. The role of inhaled prostacyclin in treating acute respiratory distress syndrome. Ther Adv Respir Dis. 2015;9(6):302-312. DOI: https://doi.org/10.1177/1753465815599345
Torbic H, Szumita PM, Anger KE, Nuccio P, LaGambina S, Weinhouse G. Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients. J Crit Care. 2013;28(5):844-848. DOI: https://doi.org/10.1016/j.jcrc.2013.03.006
Fuller BM, Mohr NM, Skrupky L, Fowler S, Kollef MH, Carpenter CR. The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis. Chest. 2015;147(6):1510-1522. DOI: https://doi.org/10.1378/chest.14-3161
Haeberle HA, Calov S, Martus P, et al. Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial. Respir Res. 2023;24:58. DOI: https://doi.org/10.1186/s12931-023-02346-0
Kataria V, Ryman K, Tsai-Nguyen G, Wakwaya Y, Modrykamien A. Evaluation of aerosolized epoprostenol for hypoxemia in non-intubated patients with coronavirus disease 2019. Hosp Pract (1995). 2022;50(2):118-123. DOI: https://doi.org/10.1080/21548331.2022.2047310
Demoule A, Vieillard Baron A, Darmon M, et al. High-Flow Nasal Cannula in Critically III Patients with Severe COVID-19. Am J Respir Crit Care Med. 2020;202(7):1039-1042. DOI: https://doi.org/10.1164/rccm.202005-2007LE
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 JAPA Academy Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.